<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1177</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2006-2-2-5-12</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>LECTURE</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЛЕКЦИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Renal pelvic and ureteric malignancies</article-title><trans-title-group xml:lang="ru"><trans-title>Злокачественные новообразования почечных лоханок и мочеточников</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Figurin</surname><given-names>K. M.</given-names></name><name xml:lang="ru"><surname>Фигурин</surname><given-names>К. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru">ГУ РОНЦ им. Н.Н. Блохина РАМН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2006-06-30" publication-format="electronic"><day>30</day><month>06</month><year>2006</year></pub-date><volume>2</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>5</fpage><lpage>12</lpage><history><date date-type="received" iso-8601-date="2020-02-18"><day>18</day><month>02</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-02-18"><day>18</day><month>02</month><year>2020</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/1177">https://oncourology.abvpress.ru/oncur/article/view/1177</self-uri><abstract xml:lang="en"><p>The lecture presents the currently available data on the prevalence of upper urinary tract tumors, their etiology and epidemiology, and anatomical pathology. The clinical manifestations of the disease are stated. The bulk of the lecture is dedicated to the diagnosis of tumors of the renal pelvis and ureter. Treatment options, such as open and endoscopic surgery, radio- and chemotherapy, are discussed.</p></abstract><trans-abstract xml:lang="ru"><p>.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Donat S.M., Herr H.W. Transitional cell carcinoma of the renal pelvis and ureter: diagnosis, staging, management, and prognosis. In: Urologic oncology. Eds. J.E. Oesterling, J. Richie, W.B. Saunders company, Philadelphia—Tokyo 1997:215—34.</mixed-citation><mixed-citation xml:lang="ru">Donat S.M., Herr H.W. Transitional cell carcinoma of the renal pelvis and ureter: diagnosis, staging, management, and prognosis. In: Urologic oncology. Eds. J.E. Oesterling, J. Richie, W.B. Saunders company, Philadelphia—Tokyo 1997:215—34.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Мебель М. Опухоли почечной лоханки и мочеточника. В кн.: Клиническая урология. Под ред. Е.Б. Маринбаха. М., 1975;57–66.</mixed-citation><mixed-citation xml:lang="ru">Мебель М. Опухоли почечной лоханки и мочеточника. В кн.: Клиническая урология. Под ред. Е.Б. Маринбаха. М., 1975;57–66.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Матвеев Б.П. Опухоли почечной лоханки и мочеточника. В кн.: Справочник по онкологии. Под ред. Н.Н. Трапезникова и И.В. Поддубной. М. 1996: 348–52.</mixed-citation><mixed-citation xml:lang="ru">Матвеев Б.П. Опухоли почечной лоханки и мочеточника. В кн.: Справочник по онкологии. Под ред. Н.Н. Трапезникова и И.В. Поддубной. М. 1996: 348–52.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Переверзев А.С., Щукин Д.В., Россихин В.В. и соавт. Опухоли почечной лоханки. В кн.: Опухоли почек и мочевых путей, Харьков, 1994:111–5.</mixed-citation><mixed-citation xml:lang="ru">Переверзев А.С., Щукин Д.В., Россихин В.В. и соавт. Опухоли почечной лоханки. В кн.: Опухоли почек и мочевых путей, Харьков, 1994:111–5.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Melamed M.R., Reuter V.E. Pathology and staging of urothelial tumors of the kidney and ureter. Urol Clin North Am 1993; 20 (2): 333.</mixed-citation><mixed-citation xml:lang="ru">Melamed M.R., Reuter V.E. Pathology and staging of urothelial tumors of the kidney and ureter. Urol Clin North Am 1993; 20 (2): 333.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Rubenstein M.A., Walz B.J., Bucy J.G. Transitional cell carcinoma of the kidney: 25-year experience. J Urol 1978; 119: 594.</mixed-citation><mixed-citation xml:lang="ru">Rubenstein M.A., Walz B.J., Bucy J.G. Transitional cell carcinoma of the kidney: 25-year experience. J Urol 1978; 119: 594.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Petkovic S., Mutavdzic M., Petronic V.L., Markovic V. Tumors of the renal pelvis and ureter: clinical and etiologic studies. J Urol Nephrol 1971;77:429.</mixed-citation><mixed-citation xml:lang="ru">Petkovic S., Mutavdzic M., Petronic V.L., Markovic V. Tumors of the renal pelvis and ureter: clinical and etiologic studies. J Urol Nephrol 1971;77:429.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Richie J.P., Kantoff P.W. Neoplasms of the renal pelvis and ureter. Cancer medicine, 4 th ed., 1997;2(124):2097—103.</mixed-citation><mixed-citation xml:lang="ru">Richie J.P., Kantoff P.W. Neoplasms of the renal pelvis and ureter. Cancer medicine, 4 th ed., 1997;2(124):2097—103.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Матвеев Б.П., Фигурин К.М. Диагностика опухолей верхних мочевых путей. Урол нефрол 1988; 5:29–34.</mixed-citation><mixed-citation xml:lang="ru">Матвеев Б.П., Фигурин К.М. Диагностика опухолей верхних мочевых путей. Урол нефрол 1988; 5:29–34.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Переверзев А.С. Хирургия опухолей почки и верхних мочевых путей. Харьков, 1997:327–52.</mixed-citation><mixed-citation xml:lang="ru">Переверзев А.С. Хирургия опухолей почки и верхних мочевых путей. Харьков, 1997:327–52.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Mufti G.R., Gove J.R., Blandy J.P. et al. Transitional cell carcinoma of the renal pelvis and ureter. Br J Urol 1989; 63: 135.</mixed-citation><mixed-citation xml:lang="ru">Mufti G.R., Gove J.R., Blandy J.P. et al. Transitional cell carcinoma of the renal pelvis and ureter. Br J Urol 1989; 63: 135.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Munoz J.J., Ellison L.M. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 2000;164(5): 1523—5.</mixed-citation><mixed-citation xml:lang="ru">Munoz J.J., Ellison L.M. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 2000;164(5): 1523—5.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. TashiroK., Nakajo H., Iwamuro S. et al. A study of tumor location and prognosis in renal pelvic and ureteral cancer. Nippon Hinyokika Gakkai Zasshi 1995: 279—82.</mixed-citation><mixed-citation xml:lang="ru">TashiroK., Nakajo H., Iwamuro S. et al. A study of tumor location and prognosis in renal pelvic and ureteral cancer. Nippon Hinyokika Gakkai Zasshi 1995: 279—82.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Charbit L., Gendreau M.C., Cukier J. et al. Tumors of the upper urinary tract: 10 years of experience. J Urol 1991;146: 1243.</mixed-citation><mixed-citation xml:lang="ru">Charbit L., Gendreau M.C., Cukier J. et al. Tumors of the upper urinary tract: 10 years of experience. J Urol 1991;146: 1243.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Al-Abadi H., Nagel R. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study. J Urol 1992; 148: 31.</mixed-citation><mixed-citation xml:lang="ru">Al-Abadi H., Nagel R. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study. J Urol 1992; 148: 31.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Kenworthy P., Tanguay S., Dinney C.P.N. The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter. J Urol 1996;155(26): 501—3.</mixed-citation><mixed-citation xml:lang="ru">Kenworthy P., Tanguay S., Dinney C.P.N. The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter. J Urol 1996;155(26): 501—3.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Oldbrig J., Glifberg I., Pawel M. et al. Carcinoma of the renal pelvis and ureter following bladder carcinoma: frequency, risk factors and clinicopathological findings. J Urol 1989; 141: 1311.</mixed-citation><mixed-citation xml:lang="ru">Oldbrig J., Glifberg I., Pawel M. et al. Carcinoma of the renal pelvis and ureter following bladder carcinoma: frequency, risk factors and clinicopathological findings. J Urol 1989; 141: 1311.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Malkowicz S.B., Skinner D.G. Development of upper tract carcinoma after cystectomy for bladder cancer. Urology 1990; 36: 20.</mixed-citation><mixed-citation xml:lang="ru">Malkowicz S.B., Skinner D.G. Development of upper tract carcinoma after cystectomy for bladder cancer. Urology 1990; 36: 20.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Herr H.W., Cookson M.S., Soloway S.M. Upper tract tumors in patients with primary bladder cancer followed for 15 years.J Urol 1996;156(4):1286.</mixed-citation><mixed-citation xml:lang="ru">Herr H.W., Cookson M.S., Soloway S.M. Upper tract tumors in patients with primary bladder cancer followed for 15 years.J Urol 1996;156(4):1286.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Kleer E., Oesterling J.E. Transitional cell carcinoma of the upper tracts. Prob Urol 1992; 6(3): 531.</mixed-citation><mixed-citation xml:lang="ru">Kleer E., Oesterling J.E. Transitional cell carcinoma of the upper tracts. Prob Urol 1992; 6(3): 531.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Ross R.K., Paganini-Hil A., Henderson B.E. Analgesics, cigarette smoking, and other risk factors for cancer of the renal pelvis and ureter. Cancer Res 1989; 49: 1045.</mixed-citation><mixed-citation xml:lang="ru">Ross R.K., Paganini-Hil A., Henderson B.E. Analgesics, cigarette smoking, and other risk factors for cancer of the renal pelvis and ureter. Cancer Res 1989; 49: 1045.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. McCredie M., Stewart J.H., Day N.E. Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis. Int J Cancer 1993; 53: 245.</mixed-citation><mixed-citation xml:lang="ru">McCredie M., Stewart J.H., Day N.E. Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis. Int J Cancer 1993; 53: 245.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Jensen O.M., Knudsen J.B., McLaughlin J.K., Sorensen B.L. The Copenhagen case-control study of renal pelvis and ureter cancer: role of smoking and occupational exposures. Int J Cancer 1988; 41: 557—61.</mixed-citation><mixed-citation xml:lang="ru">Jensen O.M., Knudsen J.B., McLaughlin J.K., Sorensen B.L. The Copenhagen case-control study of renal pelvis and ureter cancer: role of smoking and occupational exposures. Int J Cancer 1988; 41: 557—61.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. McCredie M., Ford J.M., Stewart J.H. et al. Analgesics and cancer of the renal pelvis in New South Wales. Cancer 1982; 49: 2617.</mixed-citation><mixed-citation xml:lang="ru">McCredie M., Ford J.M., Stewart J.H. et al. Analgesics and cancer of the renal pelvis in New South Wales. Cancer 1982; 49: 2617.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25. McLaughlin J.K., Silverman D.T., Fraumeni J.F. et al. Cigarette smoking, and cancer of the renal pelvis and ureter. Cancer Res 1992; 52: 254.</mixed-citation><mixed-citation xml:lang="ru">McLaughlin J.K., Silverman D.T., Fraumeni J.F. et al. Cigarette smoking, and cancer of the renal pelvis and ureter. Cancer Res 1992; 52: 254.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26. Catalona W.J. Urothelial tumors of the urinary tract. In Campbell's urology 6-th edition (ed. by P.C. Walsh) 1992: 1094—158.</mixed-citation><mixed-citation xml:lang="ru">Catalona W.J. Urothelial tumors of the urinary tract. In Campbell's urology 6-th edition (ed. by P.C. Walsh) 1992: 1094—158.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27. Johnson D.E., Babaian R.J. Conservative surgical management for non-invasive distal ureteral carcinoma. Urology 1979; 13: 365.</mixed-citation><mixed-citation xml:lang="ru">Johnson D.E., Babaian R.J. Conservative surgical management for non-invasive distal ureteral carcinoma. Urology 1979; 13: 365.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28. Hisataki T., Miyao N., Masumori N. et al. Risk factors for development of bladder cancer after upper tract urothelial cancer. Urology 2000; 55: 663—7.</mixed-citation><mixed-citation xml:lang="ru">Hisataki T., Miyao N., Masumori N. et al. Risk factors for development of bladder cancer after upper tract urothelial cancer. Urology 2000; 55: 663—7.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29. Пытель А.Я., Пытель Ю.А. Рентгенодиагностика урологических заболеваний. М. 1966: 290–92.</mixed-citation><mixed-citation xml:lang="ru">Пытель А.Я., Пытель Ю.А. Рентгенодиагностика урологических заболеваний. М. 1966: 290–92.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">30. Buckley J.A., Urban B.A., Soyer P. et al. Transitional cell carcinoma of the renal pelvis: a retrospective look at CT staging with pathologic correlation. Radiology 1996; 201 (1): 194—8.</mixed-citation><mixed-citation xml:lang="ru">Buckley J.A., Urban B.A., Soyer P. et al. Transitional cell carcinoma of the renal pelvis: a retrospective look at CT staging with pathologic correlation. Radiology 1996; 201 (1): 194—8.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">31. McCoy J.G., Honda H., Williams R.D. et al. Computerized tomography for detection and staging of localized and pathologically defined upper tract urothelial tumors. J Urol 1991;146: 1500.</mixed-citation><mixed-citation xml:lang="ru">McCoy J.G., Honda H., Williams R.D. et al. Computerized tomography for detection and staging of localized and pathologically defined upper tract urothelial tumors. J Urol 1991;146: 1500.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">32. Badalament R.A., Bennett W.F., Perez J. et al. Computed tomography of primary transitional cell carcinoma of upper urinary tracts. Urology 1992; 40 (1): 71.</mixed-citation><mixed-citation xml:lang="ru">Badalament R.A., Bennett W.F., Perez J. et al. Computed tomography of primary transitional cell carcinoma of upper urinary tracts. Urology 1992; 40 (1): 71.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">33. Mazeman E. Tumours of the upper urinary tract calyces, renal pelvis and ureter. Eur Urol 1976; 2: 120.</mixed-citation><mixed-citation xml:lang="ru">Mazeman E. Tumours of the upper urinary tract calyces, renal pelvis and ureter. Eur Urol 1976; 2: 120.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">34. Gill W.B., Lu C., Bibbo M. Retrograde brush biopsy of the ureter and renal pelvis. Urol Clin North Am 1979; 6 (3): 573.</mixed-citation><mixed-citation xml:lang="ru">Gill W.B., Lu C., Bibbo M. Retrograde brush biopsy of the ureter and renal pelvis. Urol Clin North Am 1979; 6 (3): 573.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">35. Grace D.A., Taylor W.N., Tailor J.N. Carcinoma of the renal pelvis: a 15 year review. J Urol 1967; 98: 566.</mixed-citation><mixed-citation xml:lang="ru">Grace D.A., Taylor W.N., Tailor J.N. Carcinoma of the renal pelvis: a 15 year review. J Urol 1967; 98: 566.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">36. Hawtrey C.E. Fifty-two cases of primary ureteral carcinoma: a clinical-pathologic study. J Urol 1971; 105: 188.</mixed-citation><mixed-citation xml:lang="ru">Hawtrey C.E. Fifty-two cases of primary ureteral carcinoma: a clinical-pathologic study. J Urol 1971; 105: 188.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">37. Sarnacki C.T., McCormack L.J., Kiser W.S. et al. Urinary cytology and the clinical diagnosis of urinary tract malignancy: a clinicopathologic study of 1400 patients. J Urol 1971; 106: 761.</mixed-citation><mixed-citation xml:lang="ru">Sarnacki C.T., McCormack L.J., Kiser W.S. et al. Urinary cytology and the clinical diagnosis of urinary tract malignancy: a clinicopathologic study of 1400 patients. J Urol 1971; 106: 761.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">38. Zincke H., Aguilo J.J., Farrow G.M. et al. Significance of urinary cytology in the early detection of transitional cell cancer of the upper urinary tract. J Urol 1976; 116: 781—3.</mixed-citation><mixed-citation xml:lang="ru">Zincke H., Aguilo J.J., Farrow G.M. et al. Significance of urinary cytology in the early detection of transitional cell cancer of the upper urinary tract. J Urol 1976; 116: 781—3.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">39. Blute M.L., Segura J.W., Patterson D.E. et al. Impact of endourology on diagnosis and management of upper urinary tract utothelial cancer. J Urol 1989; 141: 1298—301.</mixed-citation><mixed-citation xml:lang="ru">Blute M.L., Segura J.W., Patterson D.E. et al. Impact of endourology on diagnosis and management of upper urinary tract utothelial cancer. J Urol 1989; 141: 1298—301.</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">40. Waidelich R., Hofstetter A., Stepp H. et al. J Urol 1998; 159: 401—4.</mixed-citation><mixed-citation xml:lang="ru">Waidelich R., Hofstetter A., Stepp H. et al. J Urol 1998; 159: 401—4.</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">41. Batata M.A., Whitmore W.F. Jr Hilaris B.S. et al. Primary carcinoma of the ureter: a prognostic study. Cancer 1975; 35:1626—32</mixed-citation><mixed-citation xml:lang="ru">Batata M.A., Whitmore W.F. Jr Hilaris B.S. et al. Primary carcinoma of the ureter: a prognostic study. Cancer 1975; 35:1626—32</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">42. Bloom N.A., Vidone R.A., Lytton B. Primary carcinoma of the ureter: a report of 102 new cases. J Urol 1970; 103: 590—8.</mixed-citation><mixed-citation xml:lang="ru">Bloom N.A., Vidone R.A., Lytton B. Primary carcinoma of the ureter: a report of 102 new cases. J Urol 1970; 103: 590—8.</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">43. Guinan P., Vogelzang N.J., Sylvester J. et al. Renal pelvic cancer: a review of 611 patients treated in Illinois 1975—1985. Urology 1992; 40 (5): 393.</mixed-citation><mixed-citation xml:lang="ru">Guinan P., Vogelzang N.J., Sylvester J. et al. Renal pelvic cancer: a review of 611 patients treated in Illinois 1975—1985. Urology 1992; 40 (5): 393.</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">44. Guinan P., Vogelzang N.J., Sener S. et al. Renal pelvic transitional cell carcinoma: the role of the kidney in tumor-node-metastasis staging. Cancer 1992; 69 (7): 1773.</mixed-citation><mixed-citation xml:lang="ru">Guinan P., Vogelzang N.J., Sener S. et al. Renal pelvic transitional cell carcinoma: the role of the kidney in tumor-node-metastasis staging. Cancer 1992; 69 (7): 1773.</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">45. Blute M.L., Tsushima K., Lieber M.M. et al. Transitional cell carcinoma of the renal pelvis: nuclear deoxyribonucleic acid ploidy studied by flow cytometry. J Urol 1988; 140: 944.</mixed-citation><mixed-citation xml:lang="ru">Blute M.L., Tsushima K., Lieber M.M. et al. Transitional cell carcinoma of the renal pelvis: nuclear deoxyribonucleic acid ploidy studied by flow cytometry. J Urol 1988; 140: 944.</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">46. Лопаткин Н.А., Мартов А.Г., Ергаков Д.В. Эндоскопические методы диагностики и лечения папиллярных опухолей верхних мочевыводящих путей. Урология 2001; 3: 46–51.</mixed-citation><mixed-citation xml:lang="ru">Лопаткин Н.А., Мартов А.Г., Ергаков Д.В. Эндоскопические методы диагностики и лечения папиллярных опухолей верхних мочевыводящих путей. Урология 2001; 3: 46–51.</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">47. Mazeman E., Biserte J. Renal-sparing treatment of upper tract urothelial tumors. Curr Opin Urol 1994; 4:168.</mixed-citation><mixed-citation xml:lang="ru">Mazeman E., Biserte J. Renal-sparing treatment of upper tract urothelial tumors. Curr Opin Urol 1994; 4:168.</mixed-citation></citation-alternatives></ref><ref id="B48"><label>48.</label><citation-alternatives><mixed-citation xml:lang="en">48. Zincke H., Neves R.J. Feasibility of conservative surgery for transitional cell carcinoma of the upper tract. Urol Clin North Am 1984; 11: 717.</mixed-citation><mixed-citation xml:lang="ru">Zincke H., Neves R.J. Feasibility of conservative surgery for transitional cell carcinoma of the upper tract. Urol Clin North Am 1984; 11: 717.</mixed-citation></citation-alternatives></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">49. Freiha F.S. Renal, renal pelvis and ureteral tumors: should retroperitoneal nodes be treated? In: The lymphatic system and cancer. Eds. Meyer J.L. Basel, Karger 1994; 28: 155.</mixed-citation><mixed-citation xml:lang="ru">Freiha F.S. Renal, renal pelvis and ureteral tumors: should retroperitoneal nodes be treated? In: The lymphatic system and cancer. Eds. Meyer J.L. Basel, Karger 1994; 28: 155.</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">50. Braslis K.G., Soloway M.S. Management of ureteral and renal pelvis recurrence after cystectomy. Urol Clin North Am 1994; 21 (4): 653.</mixed-citation><mixed-citation xml:lang="ru">Braslis K.G., Soloway M.S. Management of ureteral and renal pelvis recurrence after cystectomy. Urol Clin North Am 1994; 21 (4): 653.</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">51. Gerber G.S., Lyon E.S. Endourological management of upper tract urothelial tumors. J Urol 1993; 150: 2.</mixed-citation><mixed-citation xml:lang="ru">Gerber G.S., Lyon E.S. Endourological management of upper tract urothelial tumors. J Urol 1993; 150: 2.</mixed-citation></citation-alternatives></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">52. Lim D., Shattuck M., Cook W. J. Urol 1993; 149: 109—11.</mixed-citation><mixed-citation xml:lang="ru">Lim D., Shattuck M., Cook W. J. Urol 1993; 149: 109—11.</mixed-citation></citation-alternatives></ref><ref id="B53"><label>53.</label><citation-alternatives><mixed-citation xml:lang="en">53. Martinez-Pineiro J., Matres J., Martinez-Pineiro L. et al. J Urol 1996; 156: 377—85.</mixed-citation><mixed-citation xml:lang="ru">Martinez-Pineiro J., Matres J., Martinez-Pineiro L. et al. J Urol 1996; 156: 377—85.</mixed-citation></citation-alternatives></ref><ref id="B54"><label>54.</label><citation-alternatives><mixed-citation xml:lang="en">54. Huben R.P., Mounzer A.M., Murphy G.P. Tumor grade and prognostic variables in upper tract urothelial tumors. Cancer 1988; 62: 2016.</mixed-citation><mixed-citation xml:lang="ru">Huben R.P., Mounzer A.M., Murphy G.P. Tumor grade and prognostic variables in upper tract urothelial tumors. Cancer 1988; 62: 2016.</mixed-citation></citation-alternatives></ref><ref id="B55"><label>55.</label><citation-alternatives><mixed-citation xml:lang="en">55. Borkowiski A., Malouf D. Br J Urol 1999; 83: 369—73.</mixed-citation><mixed-citation xml:lang="ru">Borkowiski A., Malouf D. Br J Urol 1999; 83: 369—73.</mixed-citation></citation-alternatives></ref><ref id="B56"><label>56.</label><citation-alternatives><mixed-citation xml:lang="en">56. Ramsey J., Soloway M. J Urol 1990; 143: 1220—2.</mixed-citation><mixed-citation xml:lang="ru">Ramsey J., Soloway M. J Urol 1990; 143: 1220—2.</mixed-citation></citation-alternatives></ref><ref id="B57"><label>57.</label><citation-alternatives><mixed-citation xml:lang="en">57. Bassi P.F. Intracavitary BCG therapy of non-invasive transitional cell carcinomas of the upper urinary tract: still investigational? Eur Urol Today 2002; 13(4): 1.</mixed-citation><mixed-citation xml:lang="ru">Bassi P.F. Intracavitary BCG therapy of non-invasive transitional cell carcinomas of the upper urinary tract: still investigational? Eur Urol Today 2002; 13(4): 1.</mixed-citation></citation-alternatives></ref><ref id="B58"><label>58.</label><citation-alternatives><mixed-citation xml:lang="en">58. Johansson S., Wahlqvist L. A prognostic study of urothelial renal pelvic tumors: comparison between the prognosis of patients treated with intrafascial nephrectomy and perifascial nephroureterectomy. Cancer 1979; 43: 2525.</mixed-citation><mixed-citation xml:lang="ru">Johansson S., Wahlqvist L. A prognostic study of urothelial renal pelvic tumors: comparison between the prognosis of patients treated with intrafascial nephrectomy and perifascial nephroureterectomy. Cancer 1979; 43: 2525.</mixed-citation></citation-alternatives></ref><ref id="B59"><label>59.</label><citation-alternatives><mixed-citation xml:lang="en">59. Dudak S.D., Soloway M.S., Neulander E.Z. Surgical management. In: Comprehensive textbook of Genitourinary Oncology second edition (eds. N.J. Vogelzang et al). 2nd ed.Lippincott Williams &amp; Wilkins, Philadelphia 2000; 24B: 378.</mixed-citation><mixed-citation xml:lang="ru">Dudak S.D., Soloway M.S., Neulander E.Z. Surgical management. In: Comprehensive textbook of Genitourinary Oncology second edition (eds. N.J. Vogelzang et al). 2nd ed.Lippincott Williams &amp; Wilkins, Philadelphia 2000; 24B: 378.</mixed-citation></citation-alternatives></ref><ref id="B60"><label>60.</label><citation-alternatives><mixed-citation xml:lang="en">60. Brookland R.K., Richter M.P. The postoperative irradiation of transitional cell carcinoma of the renal pelvis and ureter. J Urol 1985, 133: 952.</mixed-citation><mixed-citation xml:lang="ru">Brookland R.K., Richter M.P. The postoperative irradiation of transitional cell carcinoma of the renal pelvis and ureter. J Urol 1985, 133: 952.</mixed-citation></citation-alternatives></ref><ref id="B61"><label>61.</label><citation-alternatives><mixed-citation xml:lang="en">61. Sternberg C.N., Yagoda A., Scher H.I. et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium: efficacy and patterns of response and relapse. Cancer 1989; 64: 2448—58.</mixed-citation><mixed-citation xml:lang="ru">Sternberg C.N., Yagoda A., Scher H.I. et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium: efficacy and patterns of response and relapse. Cancer 1989; 64: 2448—58.</mixed-citation></citation-alternatives></ref><ref id="B62"><label>62.</label><citation-alternatives><mixed-citation xml:lang="en">62. Scher H.I., Yagoda A., Herr H.W. et al. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors. J Urol 1988; 139: 475.</mixed-citation><mixed-citation xml:lang="ru">Scher H.I., Yagoda A., Herr H.W. et al. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors. J Urol 1988; 139: 475.</mixed-citation></citation-alternatives></ref><ref id="B63"><label>63.</label><citation-alternatives><mixed-citation xml:lang="en">63. Logothetis C.J., Samuels M.L., Selig D.E. et al. Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors. Cancer Treat Rep 1985; 69: 33—38.</mixed-citation><mixed-citation xml:lang="ru">Logothetis C.J., Samuels M.L., Selig D.E. et al. Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors. Cancer Treat Rep 1985; 69: 33—38.</mixed-citation></citation-alternatives></ref><ref id="B64"><label>64.</label><citation-alternatives><mixed-citation xml:lang="en">64. Аляев Ю.Г., Винаров А.З., Крапивин А.А. Диагностика опухоли лоханки и мочеточника. В кн.: Тезисы VI Всероссийской научно-практической конференции Актуальные вопросы лечения онкоурологических заболеваний 4–5 октября 2005 г. Онкоурология (приложение) 2005: прил.: 5–6.</mixed-citation><mixed-citation xml:lang="ru">Аляев Ю.Г., Винаров А.З., Крапивин А.А. Диагностика опухоли лоханки и мочеточника. В кн.: Тезисы VI Всероссийской научно-практической конференции Актуальные вопросы лечения онкоурологических заболеваний 4–5 октября 2005 г. Онкоурология (приложение) 2005: прил.: 5–6.</mixed-citation></citation-alternatives></ref><ref id="B65"><label>65.</label><citation-alternatives><mixed-citation xml:lang="en">65. Мартов А.Г., Ергаков Д.В., Крендель Б.М., Гущин Б.Л. Нефроуретерэктомия с эндоскопической резекцией мочевого пузыря, устья и терминального отдела мочеточника при папиллярных опухолях верхних мочевых путей. Урология 2004; 5: 3–10.</mixed-citation><mixed-citation xml:lang="ru">Мартов А.Г., Ергаков Д.В., Крендель Б.М., Гущин Б.Л. Нефроуретерэктомия с эндоскопической резекцией мочевого пузыря, устья и терминального отдела мочеточника при папиллярных опухолях верхних мочевых путей. Урология 2004; 5: 3–10.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
